Abstract
Using the data from screening done in Switzerland since 1965, we showed that the probability of finding cases with increased phenylalanine or leucine concentrations is compatible with a Poisson distribution. If there are no trends present from year to year and if the Poisson distribution is an accurate fit further statistical treatment is possible. The advantage of using the Poisson distribution is exemplified by the calculation of confidence limits for the incidence of hyperphenylalaninaemia, maple syrup urine disease and hypothyroidism. Furthermore, statistical comparisons between different screening programs are easily done.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Diem, K. and Lentner, C., (eds.)Documenta Geigy, Scientific Tables, 7th edn, J. R. Geigy, Basel, 1970, pp. 107–108
Veale, A. M. O. Screening for phenylketonuria. In Bickel, H., Guthrie, R. and Hammersen, G. (eds.)Neonatal Screening for Inborn Errors of Metabolism, Springer Verlag, Berlin, 1980, p. 9
Naylor, E. W., Newborn screening for maple syrup urine disease (branched chain ketoaciduria). In Bickel, H., Guthrie, R. and Hammersen, G. (eds.)Neonatal Screening for Inborn Errors of Metabolism, Springer Verlag, Berlin, 1980, pp. 19–28
Sachs, L. (ed.) Vergleich der Mittelwerte von Poisson Verteilungen. InStatistische Auswertungsmethoden, 3rd edn, Springer Verlag, Berlin, 1972, pp. 151–153
Snedecor, G. W. and Cochran, W. G.Statistical Methods, 6th edn, Iowa State University Press, Ames, 1967, pp. 228–238
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bachmann, C., Colombo, J.P. Incidence of disorders tested by systematic screening: Confidence limits and comparison of programmes. J Inherit Metab Dis 5, 3–5 (1982). https://doi.org/10.1007/BF01799746
Issue Date:
DOI: https://doi.org/10.1007/BF01799746